Here are the S-3 shelf registrations from LB Pharmaceuticals Inc (LBRX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow LBRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LBRX filings page.
LB Pharmaceuticals Inc. has a shelf registration that permits the company and selling securityholders to offer common and preferred stock, debt securities, warrants and units, with specific terms to be set in prospectus supplements. It also includes a selling-stockholder prospectus for resales of unsold shares previously registered on a Form S-1 and additional common shares. Unless a supplement provides otherwise, the company receives no proceeds from selling-securityholder sales. For company sales, net proceeds are currently intended for general corporate purposes, including research and development, selling, general and administrative expenses, and capital expenditures.